Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04421222
Title Oral EPI-7386 in Patients With Metastatic Castration-Resistant Prostate Cancer (EPI-7386)
Acronym EPI-7386
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors ESSA Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.